Clinical Trials
55 trialsHOPE-07-MIBC
West China Hospital
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
University of Washington
HIVEC
AC.TA. S.r.l.
ACE
Dana-Farber Cancer Institute
A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
Memorial Sloan Kettering Cancer Center
RUPTURE
Poitiers University Hospital
An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models
First Affiliated Hospital of Guangxi Medical University
CALCIFER
Zealand University Hospital
Tumor Budding and T1 Substaging in Urothelial Bladder Cancer
Assiut University
Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer
Assiut University
Outcomes of Definitive Radiotherapy for Bladder Cancer
Sohag University
ACCESS-PC
Rutgers, The State University of New Jersey
ADVANCED-3
Protara Therapeutics
UroDNA
Institut Cancerologie de l'Ouest
TRIFECTA
University of Washington
RESCUE
Relmada Therapeutics, Inc.
VATSIT
VA Office of Research and Development
REDEMPTED
Brazilian Clinical Research Institute
SL-28 for Advanced Solid Tumours
Second Life Therapeutics
BLADAPT
Institut du Cancer de Montpellier - Val d'Aurelle
PERSEVERANCE
Institut Cancerologie de l'Ouest
Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
FUTURE
IRCCS San Raffaele
The Effect of Video Calls With Family Members During Operating Room Waiting on Stress, Anxiety, and Surgical Fear in Patients Undergoing Transurethral Resection of Bladder Tumor
Bitlis Eren University
Flexi-comfort
Western University, Canada
AssiutU
Assiut University
OHAI-NMIBC-01
First Affiliated Hospital of Wenzhou Medical University
No Acronym
Assiut University
NR-RC
Sir Mortimer B. Davis - Jewish General Hospital
Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer
National Cancer Center, Korea
Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer
Chinese University of Hong Kong
Antarctic Krill Oil Functional Food Mitigates Bladder Cancer Treatment Side Effects
Qilu Hospital of Shandong University
Observational Clinical Study of Patients With Muscle - Invasive Bladder Cancer Undergoing Bladder Preservation Therapy After Neoadjuvant Therapy
Peking University First Hospital
An Exploratory Clinical Study of Nimotuzumab in Bladder - Sparing Chemoradiotherapy for Muscle - Invasive Bladder Cancer
Peking University First Hospital
Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial
National Taiwan University Hospital
DIVON
Sun Yat-sen University
FAUNUS
Ankara University
A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Response by Reshaping the Tumor Microenvironment
Xijing Hospital
LIBERO
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
BIBOCYS-1
Ziekenhuis Oost-Limburg
Predictive Role of Microbiome in Patients With Urothelial Carcinoma
IRCCS San Raffaele
TUR_BLUE
A.O.U. Città della Salute e della Scienza
preSAVE
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria
Changhai Hospital
Urine DNA Methylation Detection for Hematuria Evaluation
Changhai Hospital
INu-RC
Fondazione IRCCS Policlinico San Matteo di Pavia
A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer
SUNHO(China)BioPharmaceutical CO., Ltd.